Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age
about
Conjugate vaccines for preventing meningococcal C meningitis and septicaemiaConjugate vaccines for preventing meningococcal C meningitis and septicaemiaGlobal practices of meningococcal vaccine use and impact on invasive disease.Meningococcal serogroup C conjugate vaccine.Safety and efficacy of meningococcal group C conjugate vaccines.Serologic correlates of protection for evaluating the response to meningococcal vaccines.Meningococcal vaccines: current issues and future strategies.Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.Dynamics of childhood invasive meningococcal disease in Israel during a 22-year period (1989-2010).
P2860
Q24235722-D90CC54F-81BD-4ABD-A138-26EEDFD1448DQ24244951-A64DCE18-1916-4166-82BF-FB845DA915EAQ33850840-29E91AA4-A937-4CFB-80C0-4865C0ED6151Q34482078-D3E940EB-B922-4CA6-8EB3-E20431D7B08AQ35194432-87F41691-F5FE-4FD9-9DA0-494B3872EF36Q35648260-4ADA888D-AC54-4BF2-A8F7-64DDC688E481Q38120493-32E2CD61-3434-416F-B7A8-321746C8ACDCQ38631381-9222FA98-06CE-4360-98B4-266CA82F5DA3Q44536708-D9A200D1-3B30-495A-9D25-C7F2E255664E
P2860
Safety and immunogenicity of three lots of meningococcal serogroup C conjugate vaccine administered at 2, 3 and 4 months of age
description
im April 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 April 2001
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у квітні 2001
@uk
name
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@en
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@nl
type
label
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@en
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@nl
prefLabel
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@en
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@nl
P2093
P1433
P1476
Safety and immunogenicity of t ...... ed at 2, 3 and 4 months of age
@en
P2093
J C Bramley
R B Buttery
P304
P356
10.1016/S0264-410X(00)00528-4
P407
P577
2001-04-01T00:00:00Z